PLA2G10 and metabolic disease: Finally, although the implication of group X (sPLA2‐X) in metabolic diseases is still uncertain (Sato et al., 2016), sPLA2‐X activity was associated with suppression of insulin secretion in mice (Shridas et al., 2014).